Healix Health has seen a sharp rise in claims related to chronic conditions, neurodiversity and primary care in the first half of the year.
The provider’s H1 2025 benefits usage data reveals chronic condition benefits use rose 92% year-on-year.
These benefits cover support for long-term health issues such as diabetes, asthma and heart disease. Women accounted for 63% of use, with 21% of all claims coming from women in their 30s.
Neurodiversity benefits rose 78%. These include diagnostic assessments and ongoing support for conditions such as ADHD and autism. Almost half (49%) of users came from the 0–21 age group, with autism diagnosis waits now averaging over 17 months, up 200 days in just a year.
Traditional treatments
Outpatient (55%) and inpatient/day case care (15%) accounted for 70% of claims in H1 2025, but this was in line with last year.
Physiotherapy (8%) and cash plans (7%) rounded out the top five most-used benefits, both rising from last year.
Primary care and gender-specific health benefits demand grows
Primary care consultations rose 60% in H1 2025, with over 60% of usage coming from employees under 40. This category covers consultations with a GP outside of the virtual GP service.
Gender-specific healthcare also grew 27%, with 87% of usage from women, mainly aged 30–49.
Reproductive health benefits increased 15%, with 78% of claims from women aged in their 30s.
Showing us what matters
Keira Wallis, head of clinical operations at Healix Health, said: “Employees are showing us what matters to them through the benefits they actually use.
“We’ve seen real growth in areas like chronic conditions and neurodiversity, and women’s health is clearly a much bigger part of the conversation than it was a few years ago. These are all areas where the NHS is struggling to keep up, so naturally, more people are leaning on employer-provided care to fill the gap.
“What’s interesting is that men’s health isn’t seeing the same engagement, which suggests more could be done to encourage men to use the support that’s available to them – whether at work or in the wider healthcare system.”
